EARLY‐ESLI study: Long‐term experience with eslicarbazepine acetate after first monotherapy failure

V Villanueva, P Bermejo, J Montoya… - Acta Neurologica …, 2017 - Wiley Online Library
Purpose Evaluate real‐life experience with eslicarbazepine acetate (ESL) after first
monotherapy failure in a large series of patients with focal epilepsy. Method Multicentre …
被引用次数：14 相关文章

EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

V Villanueva, P Bermejo, J Montoya… - Acta neurologica …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose Evaluate real-life experience with eslicarbazepine acetate (ESL) after first
monotherapy failure in a large series of patients with focal epilepsy. Method Multicentre …

EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.

V Villanueva, P Bermejo, J Montoya… - Acta Neurologica …, 2017 - search.ebscohost.com
Purpose Evaluate real-life experience with eslicarbazepine acetate (ESL) after first
monotherapy failure in a large series of patients with focal epilepsy. Method Multicentre …

EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.

V Villanueva, P Bermejo, J Montoya… - Acta Neurologica …, 2016 - europepmc.org
Purpose Evaluate real-life experience with eslicarbazepine acetate (ESL) after first
monotherapy failure in a large series of patients with focal epilepsy. Method Multicentre …
[PDF] academia.edu

[PDF][PDF] EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

V Villanueva, P Bermejo, J Montoya, M Toledo… - academia.edu
Purpose: Evaluate real-life experience with eslicarbazepine acetate (ESL) after first
monotherapy failure in a large series of patients with focal epilepsy. Method: Multicentre …
[PDF] academia.edu

[PDF][PDF] EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

V Villanueva, P Bermejo, J Montoya, M Toledo… - academia.edu
Purpose: Evaluate real-life experience with eslicarbazepine acetate (ESL) after first
monotherapy failure in a large series of patients with focal epilepsy. Method: Multicentre …